CPSC Announces September 4th Public Meeting to Discuss Reform Legislation
Client Alert | 1 min read | 08.18.08
The U.S. Consumer Product Safety Commission (CPSC) will hold a public meeting on Thursday, September 4, 2008, entitled "An Overview of the Consumer Safety Improvement Act of 2008." The purpose of this meeting is to address major provisions and implementation of the Consumer Product Safety Improvement Act of 2008, which calls for broad reform in the regulation of consumer product safety and the operations of the CPSC. The Act was signed into law by President Bush on Thursday, August 14, 2008.
Acting Chairman Nancy Nord and Commissioner Thomas H. Moore will provide opening remarks to meeting attendees, which will be followed by discussions by the CPSC staff of the following topics:
- Implementation of the Act and public communications;
- Provisions of general applicability contained in the Act; and
- Children's product-specific provisions contained in the Act.
The meeting will conclude with a question and answer session followed by closing remarks.
The meeting will take place on Thursday, September 4, 2008 from 9:30 a.m. to 4:30 p.m. at the U.S. Department of Commerce, Herbert C. Hoover Building Auditorium, 1401 Constitution Avenue, NW, Washington, D.C., 20230. Registration is free and open to the public.
Crowell & Moring attorneys will be in attendance at the meeting and will thereafter issue a summary of the CPSC's position regarding the new Act.
Insights
Client Alert | 5 min read | 04.23.26
CMS Proposes New Payment Policy for IOPOs and HCLs
In keeping with ongoing efforts to intensify regulatory oversight of organ procurement organizations (OPOs) and curtail improper spending within federal health programs, the Centers for Medicare & Medicaid Services (CMS) recently issued a proposed rule that would, among other adjustments, align Medicare payment policies for non-renal organs to be consistent with those currently applicable to kidneys. If enacted as drafted, this latest rule could have a direct impact on the financial stability of OPOs and histocompatibility laboratories (HCL) at a time when such organizations face increasing pressure to meet CMS’s new outcome measures — or else face non-renewal or decertification later this year.
Client Alert | 2 min read | 04.23.26
Two Lawsuits in One: The Growing Risk of Pairing Biometric Tech With Wage-and-Hour Violations
Client Alert | 3 min read | 04.22.26
Client Alert | 10 min read | 04.22.26
The EU Industrial Accelerator Act Proposal’s Significance for the Automotive Industry
